Post by PressRelease on Apr 10, 2023 5:16pm
New Press Release - NuGen Medical Commences Feasibility Study, Validation and Testing for Semaglutide - "Ozempic(R)"
Comment by
lscfa on Oct 10, 2023 1:53pm
The 4 to 5 months time frame is up. News soon? Conclusion of Phase 3, estimated at four-to-five-months, will determine a Go/No-Go outcome which will be reported to shareholders.